Mixtard Insulin Dosing Based on Blood Glucose Levels
The initial dosage of Mixtard (biphasic insulin) should be 0.1-0.2 units/kg/day, administered twice daily, with dose adjustments based on blood glucose monitoring. 1
Initial Dosing Algorithm
When starting Mixtard insulin therapy:
Calculate weight-based starting dose:
- Start with 0.1-0.2 units/kg/day total daily dose 1
- Divide into two equal doses (pre-breakfast and pre-dinner)
Blood glucose-based adjustments:
Dose Titration Protocol
- Adjust dose every 3 days based on blood glucose patterns 1
- Target fasting glucose: 80-130 mg/dL 1
- Dose adjustments:
- If fasting glucose consistently >130 mg/dL: Increase evening dose by 2 units
- If pre-dinner glucose consistently >130 mg/dL: Increase morning dose by 2 units
- If hypoglycemia occurs: Reduce corresponding dose by 10-20% 1
Mixtard Formulation Selection
Mixtard is available in different fixed-ratio formulations:
- Mixtard 30 (30% regular insulin, 70% NPH)
- Mixtard 50 (50% regular insulin, 50% NPH)
Selection should be based on blood glucose patterns:
- Mixtard 30: Standard starting formulation for most patients
- Mixtard 50: Consider for patients with significant post-breakfast hyperglycemia 2
Special Considerations
- Hypoglycemia risk: Monitor closely during initiation and dose adjustments
- Meal timing: Administer 15-30 minutes before meals
- Blood glucose monitoring: Check glucose before breakfast, before lunch, before dinner, and at bedtime initially
Correction Doses for Hyperglycemia
For blood glucose >180 mg/dL, consider adding rapid-acting insulin 1:
- 150-200 mg/dL: Add 2 units
- 201-250 mg/dL: Add 4 units
- 251-300 mg/dL: Add 6 units
300 mg/dL: Add 8 units and notify provider
Common Pitfalls to Avoid
- Inappropriate timing: Ensure Mixtard is administered 15-30 minutes before meals
- Fixed dosing: Failure to adjust doses based on blood glucose patterns
- Inadequate monitoring: Insufficient blood glucose checks during initiation phase
- Ignoring hypoglycemia: Failure to reduce dose after hypoglycemic events
- Overlooking patient education: Patients need instruction on injection technique, site rotation, and hypoglycemia management
While premixed insulin analogues like Mixtard provide convenience with fewer daily injections, they offer less flexibility than basal-bolus regimens. For patients requiring tighter glycemic control, multiple daily injections with separate basal and bolus insulins may eventually be needed 3, 1.